Vince Biemans

12PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Aboriginal and Torres Strait Islander repatriationAllergyHaematological tumoursSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 18, 2022
Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn's Disease.

E H J Savelkoul, M H J Maas, A R Bourgonje

|Jul 31, 2021
Letter: tofacitinib in treatment-refractory ulcerative colitis-a single centre real-world experience in Australia. Authors' reply.

Vince B C Biemans, Tessa Straatmijer, Frank Hoentjen

|Apr 28, 2021
Ustekinuma b for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.

Tessa Straatmijer, Vince B C Biemans, Frank Hoentjen

|Oct 21, 2020
Editorial: is age just a number when it comes to treatment of inflammatory bowel disease? Authors' reply.

Vera E R Asscher, Vince B C Biemans, Frank Hoentjen

|Oct 05, 2020
Letter: effectiveness of ustekinumab or vedolizumab in Crohn's disease following anti-TNF failure-getting closer to the truth. Authors' reply.

Vince B C Biemans, Frank Hoentjen, Marieke J Pierik

|Sep 09, 2020
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.

Vera E R Asscher, Vince B C Biemans, Marieke J Pierik

Pageof 2

Frequent Collaborators

2 joint publications

Vera E R Asscher

2 joint publications

P W Jeroen Maljaars

2 joint publications

Tessa Straatmijer

1 joint publications

E H J Savelkoul